QA: Marizyme INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001413754_2023_Marizyme_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001413754, Marizyme INC

  xvar xval
0 AssetsCurrent 1,955,303
1 IntangibleAssetsNetIncludingGoodwill 34,865,676
2 PropertyPlantAndEquipmentNet 12,545
3 remainder_Assets 1,854,114
4 LiabilitiesCurrent 2,921,767
5 LiabilitiesNoncurrent 18,343,886
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 54,358
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 15,448,488
10 remainder_Expenses 35,533,988
11 remainder_Revenues 233,493
12 remainder_NetIncome -1,089,832
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 38,687,638
1 Liabilities 21,265,653
2 Expenses 51,036,834
3 Revenues 233,493
4 StockholdersEquity 17,421,985
5 NetIncome -51,893,173
6 ComprehensiveNetIncome -51,893,173
7 BaseVar 56,156,725
8 EconomicCapitalRatiobeforeLimitedLiability -0.464
9 EconomicCapitalRatio 1.39

Edgar->Model Mapping

Feature Distribution

Change over Time